SCHEMBL2486992

SCHEMBL2486992

COc1ccc(Cn2ncc3c4c(cnc32)CNCC4)cc1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
LMNA P02545 2/20 0.46
MAPT P10636 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HPGD P15428 1/20 0.44
ALOX15 P16050 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
HSD17B10 Q99714 1/20 0.44
PDE1B Q01064 6/20 0.44
NPBWR1 P48145 3/20 0.40
PDE1A P54750 3/20 0.39
PDE1C Q14123 3/20 0.39
CNR2 P34972 3/20 0.39
PDE5A O76074 1/20 0.38
MCHR1 Q99705 1/20 0.37
MET P08581 1/20 0.37
PKM P14618 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12338757 0.81 PDE1B (0.43) PDE1BNPBWR1CNR2PDE5A
SCHEMBL2489846 0.80 ABCB1 (0.47) ALDH1A1LMNAMAPTSMN1; SMN2HPGD
SCHEMBL12315714 0.80 ALDH1A1 (0.48) ALDH1A1LMNAMAPTSMN1; SMN2HPGD
SCHEMBL12315712 0.80 PDE1B (0.42) PDE1BNPBWR1CNR2PDE5AMET
SCHEMBL2486174 0.79 LMNA (0.45) ALDH1A1LMNAMAPTSMN1; SMN2HPGD
SCHEMBL12315715 0.77 LMNA (0.46) ALDH1A1LMNAMAPTSMN1; SMN2HPGD
Hydrochloric Acid SCHEMBL28948243 0.77 NPBWR1 (0.44) ALDH1A1MAPTALOX15PDE1BNPBWR1
SCHEMBL2488863 0.76 ALDH1A1 (0.43) ALDH1A1LMNAMAPTSMN1; SMN2HPGD
SCHEMBL2490474 0.76 ALDH1A1 (0.43) ALDH1A1LMNAMAPTSMN1; SMN2HPGD
SCHEMBL2486745 0.76 ALDH1A1 (0.42) ALDH1A1LMNAMAPTSMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8263610-B2 Substituted imidazolyl-5,6-dihydrobenzo[N]isoquinoline compounds ARQULE, INC. (US) 2012-09-11 US disclosed
US-8263610-B2 Substituted imidazolyl-5,6-dihydrobenzo[N]isoquinoline compounds ARQULE, INC. (US) 2012-09-11 US disclosed
US-8263610-B2 Substituted imidazolyl-5,6-dihydrobenzo[N]isoquinoline compounds ARQULE, INC. (US) 2012-09-11 US disclosed
EP-2379551-A1 SUBSTITUTED PYRAZOLO [3, 4-B]PYRIDINE COMPOUNDS ArQule, Inc. (US) 2011-10-26 EP disclosed
US-20100239526-A1 SUBSTITUTED IMIDAZOLYL-5,6-DIHYDROBENZO[N]ISOQUINOLINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
US-20100239526-A1 SUBSTITUTED IMIDAZOLYL-5,6-DIHYDROBENZO[N]ISOQUINOLINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
US-20100239526-A1 SUBSTITUTED IMIDAZOLYL-5,6-DIHYDROBENZO[N]ISOQUINOLINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
WO-2010078427-A1 SUBSTITUTED PYRAZOLO [3, 4-B] PYRIDINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 WO disclosed
WO-2010078427-A1 SUBSTITUTED PYRAZOLO [3, 4-B] PYRIDINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239526-A1 SUBSTITUTED IMIDAZOLYL-5,6-DIHYDROBENZO[N]ISOQUINOLINE COMPOUNDS NQO1, IDH3B, IDH1 ALDH1A1 460/4885LMNA 1591/4885MAPT 3332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.